Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies

Brenda J. Weigel, Sarah Cooley, Todd Defor, Daniel J. Weisdorf, Angela Panoskaltsis-Mortari, Wei Chen, Bruce R. Blazar, Jeffrey S. Miller

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences